A key reason for the success of its Zepbound drug is its status as a "dual agonist." Wegovy targets only GLP-1 receptors, whereas tirzepatide (aka Zebound) targets both GLP-1 and GIP receptors, leading to greater overall weight loss
Para Mounjaro (diabetes), se comienza con 2.5 mg semanales y se aumenta cada 4 semanas
PlexusDx connects this information to accessible, affordable compounded semaglutide ($189/mo) and tirzepatide options ($289/mo), ensuring you have evidence-based medication access regardless of your long-term strategy
However, for maintaining results, we teach you how to make healthy life choices that promote wellness and longevity
Ongoing Medical Supervision GLP-1 medications require monitoring for side effects and effectiveness
Best total value for cash-pay buyers